The main pathways involved in increased osteoclast formation in multiple myeloma are osteoprotegerin (OPG), macrophage inflammatory protein (MIP)-1α, IL-6, IL-3 and RANK ligand (RANKL). The gene discussed is TNFRSF11B; the disease is AL amyloidosis.